Parian Global Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.9M Sell
527,126
-205,840
-28% -$1.14M 9.44% 2
2022
Q2
$2.67M Sell
732,966
-6,199
-0.8% -$29.3K 12.25% 3
2022
Q1
$4.47M Sell
739,165
-252,064
-25% -$1.54M 9.21% 2
2021
Q4
$8.36M Buy
991,229
+170,841
+21% +$1.49M 6.71% 3
2021
Q3
$7.43M Buy
+820,388
New +$7.05M 5.19% 5

Other funds holding APEN

Parian Global Management's APEN Position: Q3 2022 in Review

Parian Global Management reduced its Apollo Endosurgery, Inc. (APEN) stake by 28% in Q3 2022, selling an estimated $1.14M and leaving 527,126 shares worth $2.9M. The position accounts for 9.44% of the portfolio, ranked #2.

Parian Global Management first reported a position in APEN in Q3 2021 and has held it in 5 quarters since. The position peaked at $8.36M in Q4 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

  • Parian Global Management held 527,126 shares of Apollo Endosurgery, Inc. worth $2.9M as of Q3 2022.
  • Parian Global Management sold 205,840 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $1.14M.
  • Apollo Endosurgery, Inc. made up 9.44% of Parian Global Management's portfolio in Q3 2022, its #2 holding.
  • Parian Global Management first reported a position in Apollo Endosurgery, Inc. in Q3 2021 and has held it in 5 quarters since.
  • Parian Global Management's Apollo Endosurgery, Inc. position peaked at $8.36M in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.